Company Overview of Innocutis Medical, LLC
Innocutis Medical, LLC, a pharmaceutical and medical device company, specializing in the development and commercialization of therapies and devices focused on medical treatment of dermatological conditions. It offers Nuvail, a polymer for managing signs and symptoms of nail dystrophy; Bionect for managing redness, inflammation, and discomfort associated with irritations of the skin; Inova acne control therapy; EcoFormula, a hydro-soluble lacquer for improving the appearance of dry, brittle, and damaged nails; and Pro:12 Mousse, a pharmaceutical-grade moisturizer for the repair and rebuilding of distressed skin. The company also provides Umecta PD for restoring skin barrier function; Umecta N...
141 Church Street
Charleston, SC 29401
Founded in 2010
Key Executives for Innocutis Medical, LLC
Chief Executive Officer and President
Vice President of Sales & Marketing
Compensation as of Fiscal Year 2014.
Innocutis Medical, LLC Key Developments
Innocutis Holdings Introduces Sitavig in U.S
Jul 29 14
BioAlliance Pharma SA reported the launch of Sitavig (acyclovir Lauriad) in the United States by its commercial partner, Innocutis Holdings, and the granting of a new U.S. Sitavig patent by the United States Patent and Trademark Office. A few weeks after the execution of a licensing agreement between the two companies, Innocutis has begun the promotion of Sitavig in the U.S. for the treatment of labial herpes to dermatologists and top tier general practitioners.
Innocutis Medical, LLC Announces the FDA Approval of Nuvail for the Treatment of Nail Dystrophy
Sep 18 12
Innocutis Medical, LLC announced the FDA approval of Nuvail nail solution, a novel prescription product to help manage fragile, damaged or brittle nails with cracking or splitting, a condition medically referred to as nail dystrophy. Among the most common forms of nail dystrophy is Brittle Nail Syndrome (BNS), which often is referred to simply as brittle nails.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries